Novadip Biosciences has secured €10.4 million in convertible financing to [...]

MaaT Pharma plans to advance a global Phase 3 trial [...]

Resolution Therapeutics has partnered with Blood Centers of America to [...]

Resolution Therapeutics has treated the final patient in its Phase [...]

Circio has raised approximately NOK 200M (€18.6M) to advance its [...]

Circio and Full Circles Therapeutics are combining circular RNA and [...]

CellProthera and Alfresa Holdings have signed an MOU covering potential [...]

Obsidian Therapeutics has enrolled the first patient in the registration-enabling [...]

Circio is preparing to advance its circular RNA gene therapy [...]

A Phase 1/1b clinical trial has begun in Australia to [...]